Vanavond een heel mooie deal met Fuji Pharma aangekondigd. Dit soort deals zitten we op te wachten:
Liège, Belgium 31 August 2016 - Mithra Pharmaceuticals, a company dedicated to Women’s Health, is extremely pleased to announce it has signed its first major partnership agreement for Estelle®.
Only two months after the LOI between Mithra and Fuji, announced on 24 June 2016, Mithra today announces it has signed a 20-year exclusive license and supply agreement for Estelle® with Fuji Pharma, the Japanese leader in Women’s Health and Japanese market leader in
contraception and dysmenorrhea.
Under the terms of the agreements, Mithra will, depending on the progress of the development, receive a total down payment consideration
of up to EUR 26 million of which EUR 10 million as an upfront signature milestone. In addition, the agreements comprise an exclusive supply obligation for the duration, which in the future will provide Mithra’s CDMO with a steady flow of production work for Estetrol-based products, and Mithra with a source of revenue and margin over the entire term.
Morgen de cijfers. Ik ben benieuwd.